Telsey Advisory Group Issues Pessimistic Forecast for Vital Farms (NASDAQ:VITL) Stock Price

Vital Farms (NASDAQ:VITL) had its target price lowered by analysts at Telsey Advisory Group from $50.00 to $35.00 in a report released on Friday, Marketbeat Ratings reports. The firm presently has an “outperform” rating on the stock. Telsey Advisory Group’s target price points to a potential upside of 65.96% from the company’s previous close.

Other equities analysts also recently issued research reports about the company. DA Davidson set a $47.00 target price on Vital Farms and gave the company a “buy” rating in a research report on Wednesday, December 17th. TD Cowen reaffirmed a “buy” rating on shares of Vital Farms in a research note on Tuesday, January 20th. Benchmark lowered shares of Vital Farms from a “buy” rating to a “hold” rating in a report on Thursday. Weiss Ratings reissued a “hold (c+)” rating on shares of Vital Farms in a research note on Monday, December 29th. Finally, Needham & Company LLC restated a “buy” rating and set a $45.00 price target on shares of Vital Farms in a research report on Friday, January 30th. Nine research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, Vital Farms has an average rating of “Moderate Buy” and an average price target of $46.64.

Vital Farms Stock Down 4.6%

Shares of NASDAQ VITL opened at $21.09 on Friday. The firm has a market cap of $944.41 million, a price-to-earnings ratio of 14.65 and a beta of 1.10. The company’s 50-day simple moving average is $28.60 and its 200-day simple moving average is $36.06. The company has a quick ratio of 2.15, a current ratio of 2.65 and a debt-to-equity ratio of 0.02. Vital Farms has a 52-week low of $19.80 and a 52-week high of $53.13.

Vital Farms (NASDAQ:VITL) last released its quarterly earnings results on Thursday, February 26th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.03). Vital Farms had a return on equity of 21.38% and a net margin of 8.73%.The company had revenue of $213.55 million for the quarter, compared to analyst estimates of $212.83 million. During the same quarter last year, the company earned $0.23 EPS. The firm’s revenue for the quarter was up 28.6% on a year-over-year basis. Equities analysts predict that Vital Farms will post 1.11 EPS for the current fiscal year.

Insider Activity

In related news, CEO Russell Diez-Canseco sold 16,734 shares of the firm’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $35.05, for a total transaction of $586,526.70. Following the completion of the sale, the chief executive officer directly owned 649,684 shares in the company, valued at approximately $22,771,424.20. This trade represents a 2.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Matthew Ohayer sold 25,000 shares of Vital Farms stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $30.85, for a total transaction of $771,250.00. Following the transaction, the insider directly owned 6,361,190 shares in the company, valued at $196,242,711.50. This trade represents a 0.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 91,734 shares of company stock worth $2,921,477. Corporate insiders own 21.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in VITL. Principal Financial Group Inc. raised its stake in shares of Vital Farms by 23.1% in the third quarter. Principal Financial Group Inc. now owns 1,377,681 shares of the company’s stock valued at $56,692,000 after acquiring an additional 258,092 shares in the last quarter. Hussman Strategic Advisors Inc. purchased a new stake in Vital Farms during the 3rd quarter worth about $1,728,000. Geode Capital Management LLC raised its position in Vital Farms by 2.4% in the 2nd quarter. Geode Capital Management LLC now owns 807,003 shares of the company’s stock valued at $31,089,000 after purchasing an additional 18,682 shares in the last quarter. E. Ohman J or Asset Management AB purchased a new position in shares of Vital Farms in the 3rd quarter valued at about $1,903,000. Finally, Quantbot Technologies LP acquired a new position in shares of Vital Farms during the second quarter worth about $4,571,000. 98.59% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Vital Farms

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Q4 revenue growth and top‑line clarity — Revenue rose ~28.6% year‑over‑year and Q4 revenue came in essentially inline with expectations, showing continued demand and scale benefits. This supports the company’s growth story even though EPS missed. MarketBeat / Press Release
• Neutral Sentiment: Board leadership transition — Founder Matt O’Hayer stepped down as Executive Chair; CEO Russell Diez‑Canseco was named Executive Chair to maintain continuity. This reduces governance uncertainty short‑term but is unlikely to change fundamentals immediately. Business Wire
• Negative Sentiment: EPS miss and mixed guidance reaction — Q4 EPS of $0.35 missed the $0.38 consensus (revenues roughly inline). Several outlets highlight the profit shortfall and guidance interpretation that disappointed some investors, which directly pressured the stock. Zacks
• Negative Sentiment: Securities‑class investigation announced — The Rosen Law Firm has opened an investigation alleging Vital Farms may have provided materially misleading information to investors. Such filings often increase short‑term selling pressure and can raise legal risk and potential future costs. GlobeNewswire
• Negative Sentiment: Analyst revisions and target cuts — Multiple firms updated coverage: Benchmark downgraded to “hold,” Morgan Stanley trimmed its price target to $24 (from $45), and Telsey cut its target to $35 while keeping an outperform stance. These moves reduce near‑term upside expectations and can amplify selling. Benzinga

Vital Farms Company Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.